|
Re: Context on Sales Potential for an oral anti-viral & anti-inflammation combo
|
2
|
Resverlogix Corp.
|
Apr 15, 2021 01:44PM
|
|
Re: Context on Sales Potential for an oral anti-viral & anti-inflammation combo
|
6
|
Resverlogix Corp.
|
Apr 15, 2021 04:11PM
|
|
Re: Contest Tally- Waste of board space
|
4
|
Resverlogix Corp.
|
Feb 12, 2019 05:15PM
|
|
Re: Contest Tally - Cut Off Tonight 9 pm EST
|
4
|
Resverlogix Corp.
|
Jul 23, 2019 01:31AM
|
|
Re: Contest Tally - Cut Off Tonight 9 pm EST
|
3
|
Resverlogix Corp.
|
Jul 23, 2019 07:23AM
|
|
Re: Contest Tally
|
3
|
Resverlogix Corp.
|
Feb 12, 2019 01:51PM
|
|
Re: Contest Tally
|
6
|
Resverlogix Corp.
|
Feb 21, 2019 10:54AM
|
|
Re: Contest Tally
|
2
|
Resverlogix Corp.
|
Feb 19, 2019 08:36PM
|
|
Re: Constellation Pharma
|
7
|
Resverlogix Corp.
|
Jun 29, 2020 07:54PM
|
|
Re: Connecting the Dots II - Royalty Preferred Shares
|
4
|
Resverlogix Corp.
|
Feb 17, 2019 12:46PM
|
|
Re: Congratulations To.....
|
2
|
Resverlogix Corp.
|
Dec 11, 2019 12:47AM
|
|
Re: Congratulations to Imtesty on winning the Share Price Contest
|
3
|
Resverlogix Corp.
|
Nov 19, 2019 04:32PM
|
|
Re: Congratulations to Imtesty on winning the Share Price Contest
|
1
|
Resverlogix Corp.
|
Nov 19, 2019 08:55PM
|
|
Re: Confirmation bias.....
|
2
|
Resverlogix Corp.
|
May 02, 2017 12:34PM
|
|
Re: Confirmation bias.....
|
3
|
Resverlogix Corp.
|
May 01, 2017 09:05PM
|
|
Re: Confirmation bias.....
|
2
|
Resverlogix Corp.
|
May 02, 2017 02:33AM
|
|
Re: Concerns Mount Over COVID-19 'Rebounds' After Treatment With Pfizer's Paxlovid
|
8
|
Resverlogix Corp.
|
Jun 02, 2022 01:26PM
|
|
Re: Compilation of BET inhibitor Trials
|
2
|
Zenith Epigenetics
|
Oct 05, 2017 10:29PM
|
|
Re: Competition
|
4
|
Resverlogix Corp.
|
Nov 29, 2021 01:24PM
|
|
Re: Comparison to other trials
|
3
|
Resverlogix Corp.
|
Dec 05, 2019 01:18AM
|
